Prescient Therapeutics Limited (AU:PTX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Prescient Therapeutics Limited has reported a change in Director Allen James Ebens Jr.’s interests, with the expiry of 415,000 unlisted options. Ebens now holds 1,000,000 unlisted options, exercisable at $0.0968 each, set to expire on 23 November 2024. The change, which involved no monetary transaction, was detailed in a formal notice to the ASX, as per the listing rules.
For further insights into AU:PTX stock, check out TipRanks’ Stock Analysis page.